Cargando…

Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates

INTRODUCTION: The pharmacokinetics of vancomycin are highly variable among neonates, which makes dosing challenging in this population. However, adequate drug exposure is critical, especially when treating methicillin-resistant Staphylococcus aureus (MRSA) infections. Utilization of population pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stockmann, Chris, Hersh, Adam L., Roberts, Jessica K., Bhongsatiern, Jiraganya, Korgenski, Ernest K., Spigarelli, Michael G., Sherwin, Catherine M. T., Frymoyer, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471056/ https://www.ncbi.nlm.nih.gov/pubmed/25998107 http://dx.doi.org/10.1007/s40121-015-0067-9

Ejemplares similares

Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
por: Stockmann, Chris, et al.
Publicado: (2016)

Predicting tacrolimus concentrations in children receiving a heart transplant using a population pharmacokinetic model
por: Rower, Joseph E, et al.
Publicado: (2017)

Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set
por: Hughes, Jasmine H., et al.
Publicado: (2022)

High-Dose Erythropoietin Population Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
por: Frymoyer, Adam, et al.
Publicado: (2017)

Bioequivalence and Bioavailability Clinical Trials: A Status Report from the National Institutes of Health ClinicalTrials.gov Registry
por: Stockmann, Chris, et al.
Publicado: (2013)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
por: Ling, I-Fang, et al.
Publicado: (2012)

Population pharmacokinetics of vancomycin in very low birth weight neonates
por: Alsultan, Abdullah, et al.
Publicado: (2023)

Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations
por: Li, Zhi-ling, et al.
Publicado: (2018)

122 Clinical and Microbiologic Characteristics of Pediatric Patients with Lemierre Syndrome
por: Nuibe, Andrew, et al.
Publicado: (2014)

Clinical pharmacokinetics of vancomycin in the neonate: a review
por: Pacifici, Gian Maria, et al.
Publicado: (2012)

Population Pharmacokinetics of Vancomycin in Pregnant Women
por: Goyal, Rahul K., et al.
Publicado: (2022)

Theophylline Dosing and Pharmacokinetics for Renal Protection in Neonates with Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
por: Frymoyer, Adam, et al.
Publicado: (2020)

Neonatal Magnesium Levels Correlate with Motor Outcomes in Premature Infants: A Long-Term Retrospective Cohort Study
por: Doll, Elizabeth, et al.
Publicado: (2014)

Population Pharmacokinetics of Intraventricular Vancomycin in Neonatal Ventriculitis, A Preterm Pilot Study
por: Parasuraman, Jaya Madhura, et al.
Publicado: (2021)

A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures
por: Veesenmeyer, Angela Fimbres, et al.
Publicado: (2016)

Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates
por: Yu, Tian, et al.
Publicado: (2016)

Population Pharmacokinetics of Vancomycin in Thai Patients
por: Purwonugroho, Tunggul Adi, et al.
Publicado: (2012)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
por: Mulubwa, Mwila, et al.
Publicado: (2020)

Laboratory-Confirmed Human Coronavirus Infections Among Children: Does Type Matter?
por: Sanderson, Susan K., et al.
Publicado: (2016)

A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants
por: Song, Lin, et al.
Publicado: (2017)

Aminophylline for Renal Protection in Neonatal Hypoxic Ischemic Encephalopathy in the Era of Therapeutic Hypothermia
por: Chock, Valerie Y., et al.
Publicado: (2020)

Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
por: Zylbersztajn, Brenda, et al.
Publicado: (2021)

Population pharmacokinetic model of vancomycin in postoperative neurosurgical patients
por: Wei, Shifeng, et al.
Publicado: (2022)

Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1–18 Years
por: Smit, Cornelis, et al.
Publicado: (2021)

Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
por: Frymoyer, Adam, et al.
Publicado: (2020)

Predictive performance of Vancomycin population pharmacokinetic models in Iranian patients underwent hematopoietic stem cell transplantation
por: Taghizadeh-Ghehi, Maryam, et al.
Publicado: (2015)

Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates
por: Matcha, Saikumar, et al.
Publicado: (2023)

External Evaluation of Vancomycin Population Pharmacokinetic Models at Two Clinical Centers
por: Liu, Yi-Xi, et al.
Publicado: (2021)

Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients
por: Shoji, Kensuke, et al.
Publicado: (2021)

Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study
por: Donadello, Katia, et al.
Publicado: (2014)

Incidence of Neonatal Hypothermia in the Newborn Nursery and Associated Factors
por: Dang, Rebecca, et al.
Publicado: (2023)

Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis
por: Lam, Edwin, et al.
Publicado: (2021)

Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal Population
por: O’Hara, Kate, et al.
Publicado: (2020)

Preventable infections in children with leukodystrophy
por: Anderson, Holly M, et al.
Publicado: (2014)

Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
por: Monteiro, Joaquim F., et al.
Publicado: (2018)

Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization
por: Ma, Kui-fen, et al.
Publicado: (2020)

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals
por: Smit, Cornelis, et al.
Publicado: (2020)

Clinical application of vancomycin population pharmacokinetics model in patients with hematological diseases and neutropenia
por: Fu, Xiangjun, et al.
Publicado: (2021)

Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series
por: Onor, IfeanyiChukwu O., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2mrc5l5sumk5jrj3r098v3nc4f